| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 927 | 16,975 | ||
| Goods and services tax receivable | 17,628 | 23,204 | ||
| Accounts receivable | 588,393 | 114,307 | ||
| Inventory | 863,807 | 1,043,538 | ||
| Total current assets | 1,470,755 | 1,198,024 | ||
| Equipment, net | 123,333 | 129,389 | ||
| Right-of-use building, net | 5,504,692 | 5,627,215 | ||
| Investments | 4,518,127 | 4,518,127 | ||
| Total assets | 11,616,907 | 11,472,755 | ||
| Accounts payable and accrued liabilities | 10,189,279 | 10,012,932 | ||
| Accrued interest | 1,522,539 | 3,865,183 | ||
| Notes payable | 478,604 | 483,874 | ||
| Convertible notes | 1,017,003 | 1,298,114 | ||
| Derivative conversion feature | 556,755 | 564,051 | ||
| Loans payable to related parties, current portion | 11,885,572 | - | ||
| Royalty payable | 287,035 | 56,405 | ||
| Loans payable to related parties | - | 9,941,556 | ||
| Liability for right-of-use building, current portion | 985,027 | 1,005,099 | ||
| Obligation to issue shares | 1,558,710 | 1,727,065 | ||
| Total current liabilities | 28,480,524 | 28,954,279 | ||
| Loans payable to related parties | 679,397 | - | ||
| Liability for right-of-use building | 4,973,729 | 5,092,561 | ||
| Preferred stock, value-Series BPreferred Stock | - | 455,000 | ||
| Total liabilities | 34,133,650 | 34,046,840 | ||
| Preferred stock, value-Series APreferred Stock | 74,416 | 74,416 | ||
| Preferred stock, value-Series DPreferred Stock | 455,000 | - | ||
| Preferred stock, value-Series CPreferred Stock | 100,000 | 100,000 | ||
| Common shares, 0.0001 par value 5,000,000,000 shares authorized, 662,501,405 issued and outstanding as at september 30, 2025 and december 31, 2024 | 66,250 | 66,250 | ||
| Treasury shares, 0.0001 par value 6,230,761 shares as at september 30, 2025 and december 31, 2024 | 623 | 623 | ||
| Additional paid-in capital | 81,379,443 | 80,122,590 | ||
| Accumulated deficit | -104,766,005 | -103,288,194 | ||
| Accumulated other comprehensive income | 173,530 | -104,770 | ||
| Total shareholders' deficit | -22,516,743 | -22,574,085 | ||
| Total liabilities and shareholders' deficit | 11,616,907 | 11,472,755 | ||
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)